The emerging role of FAM46C as a biomarker and therapeutic target in gastric adenocarcinoma
Open Access
- 1 August 2024
- journal article
- research article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 15 (4) , 1870-1879
Abstract
Review Article The emerging role of FAM46C as a biomarker and therapeutic target in gastric adenocarcinoma Shelly Luu, Ning Fu, Paul Savage, Karina Pacholczyk, Taylor Zaslavsky, James Conner, Carol J. SwallowKeywords
This publication has 27 references indexed in Scilit:
- Global burden of gastric cancer: epidemiological trends, risk factors, screening and preventionNature Reviews Clinical Oncology, 2023
- Investigating the mechanisms of peritoneal metastasis in gastric adenocarcinoma using a novel ex vivo peritoneal explant modelScientific Reports, 2022
- FAM46A expression is elevated in glioblastoma and predicts poor prognosis of patientsClinical Neurology and Neurosurgery, 2021
- FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activityCommunications Biology, 2020
- Structural and Functional Analyses of the FAM46C/Plk4 ComplexStructure, 2020
- Down-regulation of miR-10b represses cell vitality in osteosarcoma and is inversely associated with prognosis via interacting with FAM46CTissue and Cell, 2020
- The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myelomaNature Communications, 2017
- FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cellsScientific Reports, 2017
- Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional AnalysisJournal of the American College of Surgeons, 2014
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted TherapyCancer Cell, 2014